Govindaraju D, Kao H, Chien Y, Chen J
Int J Mol Sci. 2024; 25(18).
PMID: 39337295
PMC: 11432067.
DOI: 10.3390/ijms25189803.
Tomero-Sanz H, Jimenez-Heffernan J, Fernandez-Chacon M, Cristobal-Garcia I, Sainz de la Cuesta R, Gonzalez-Cortijo L
Cancers (Basel). 2024; 16(15).
PMID: 39123425
PMC: 11311419.
DOI: 10.3390/cancers16152697.
Choi E
BMC Vet Res. 2023; 19(1):89.
PMID: 37480011
PMC: 10362594.
DOI: 10.1186/s12917-023-03655-8.
Malakoti F, Targhazeh N, Abadifard E, Zarezadeh R, Samemaleki S, Asemi Z
Cancer Cell Int. 2022; 22(1):176.
PMID: 35501851
PMC: 9063177.
DOI: 10.1186/s12935-022-02597-9.
Lapidot M, Case A, Larios D, Gandler H, Meng C, Tosic I
Cancers (Basel). 2020; 13(1).
PMID: 33374980
PMC: 7792575.
DOI: 10.3390/cancers13010007.
Targeting Calcium Signalling in Malignant Mesothelioma.
Martinotti S, Patrone M, Moccia F, Ranzato E
Cancers (Basel). 2019; 11(12).
PMID: 31766522
PMC: 6966506.
DOI: 10.3390/cancers11121839.
Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin.
Worthmuller J, Salicio V, Oberson A, Blum W, Schwaller B
Int J Mol Sci. 2019; 20(21).
PMID: 31671889
PMC: 6873109.
DOI: 10.3390/ijms20215391.
Preparation of Gelatin and Gelatin/Hyaluronic Acid Cryogel Scaffolds for the 3D Culture of Mesothelial Cells and Mesothelium Tissue Regeneration.
Kao H, Kuo C, Chen K, Chen J
Int J Mol Sci. 2019; 20(18).
PMID: 31547444
PMC: 6770111.
DOI: 10.3390/ijms20184527.
Cytosolic Ca Buffers Are Inherently Ca Signal Modulators.
Schwaller B
Cold Spring Harb Perspect Biol. 2019; 12(1).
PMID: 31308146
PMC: 6942125.
DOI: 10.1101/cshperspect.a035543.
Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway.
Worthmuller J, Blum W, Pecze L, Salicio V, Schwaller B
Oncotarget. 2018; 9(91):36256-36272.
PMID: 30555628
PMC: 6284738.
DOI: 10.18632/oncotarget.26332.
Calretinin Functions in Malignant Mesothelioma Cells Cannot Be Replaced by the Closely Related Ca-Binding Proteins Calbindin-D28k and Parvalbumin.
Worthmuller J, Oberson A, Salicio V, Blum W, Schwaller B
Int J Mol Sci. 2018; 19(12).
PMID: 30545133
PMC: 6321210.
DOI: 10.3390/ijms19124015.
Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2 mice and mouse mesothelioma cell lines from various mouse strains.
Blum W, Henzi T, Chatel-Soulet H, Pecze L, Rodriguez J, Vrugt B
Biomark Res. 2018; 6:19.
PMID: 29928505
PMC: 5989366.
DOI: 10.1186/s40364-018-0132-0.
Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter.
Blum W, Pecze L, Rodriguez J, Steinauer M, Schwaller B
BMC Cancer. 2018; 18(1):475.
PMID: 29699512
PMC: 5922012.
DOI: 10.1186/s12885-018-4385-7.
Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration.
Blum W, Pecze L, Felley-Bosco E, Schwaller B
Respir Res. 2015; 16:153.
PMID: 26695618
PMC: 4699379.
DOI: 10.1186/s12931-015-0311-6.
Toll/IL-1 domain-containing adaptor inducing IFN-β (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation.
Hwang E, Kim T, Oh S, Lee K, Yang S, Park J
Cytokine. 2015; 77:127-34.
PMID: 26579632
PMC: 7128242.
DOI: 10.1016/j.cyto.2015.11.010.
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
van Zandwijk N, Clarke C, Henderson D, William Musk A, Fong K, Nowak A
J Thorac Dis. 2014; 5(6):E254-307.
PMID: 24416529
PMC: 3886874.
DOI: 10.3978/j.issn.2072-1439.2013.11.28.
Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.
Chowdhuri S, Fetsch P, Squires J, Kohn E, Filie A
Diagn Cytopathol. 2012; 42(3):253-8.
PMID: 23161830
PMC: 7682751.
DOI: 10.1002/dc.22915.
TLE1 expression in malignant mesothelioma.
Matsuyama A, Hisaoka M, Iwasaki M, Iwashita M, Hisanaga S, Hashimoto H
Virchows Arch. 2010; 457(5):577-83.
PMID: 20857142
DOI: 10.1007/s00428-010-0975-8.
Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.
Sandeck H, Roe O, Kjaerheim K, Willen H, Larsson E
Diagn Pathol. 2010; 5:47.
PMID: 20602796
PMC: 2915960.
DOI: 10.1186/1746-1596-5-47.
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.
Raiko I, Sander I, Weber D, Raulf-Heimsoth M, Gillissen A, Kollmeier J
BMC Cancer. 2010; 10:242.
PMID: 20509881
PMC: 2886046.
DOI: 10.1186/1471-2407-10-242.